LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

LLY

986

-0.26%↓

JNJ

224.47

-0.51%↓

ABBV

204.99

-0.5%↓

UNH

366.96

+0.87%↑

AZN

184.44

+1.73%↑

Начало・Списък с акции・Odonate Therapeutics Inc

O
Odonate Therapeutics Inc

Затворен

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Odonate Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

6.05.2026 г., 23:41 ч. UTC

Печалби

Arm Holdings Lacks Supply to Meet Roaring Demand for New Chips -- Update

6.05.2026 г., 21:40 ч. UTC

Печалби

Nutrien Logs Higher Profit, Sales Growth in 1Q

6.05.2026 г., 23:47 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

6.05.2026 г., 23:34 ч. UTC

Пазарно говорене

Gold Prices Steady, Supported by Lower U.S. Treasury Yields -- Market Talk

6.05.2026 г., 23:13 ч. UTC

Печалби

Kakao 1Q Net Profit Beat FactSet-Compiled Consensus

6.05.2026 г., 23:13 ч. UTC

Печалби

Kakao 1Q Net KRW226.84B Vs. Net KRW200.33B >035720.SE

6.05.2026 г., 23:12 ч. UTC

Печалби

Kakao 1Q Oper Pft KRW211.40B Vs. Pft KRW105.40B >035720.SE

6.05.2026 г., 23:11 ч. UTC

Печалби

Kakao 1Q Rev KRW1.942T Vs. KRW1.864T >035720.SE

6.05.2026 г., 23:11 ч. UTC

Печалби

United Overseas Bank's CEO: Low Single-Digit Loan Growth Outlook for 2026 >U11.SG

6.05.2026 г., 23:11 ч. UTC

Печалби

United Overseas Bank's CEO: 2026 Outlook for Total Credit Costs at 25-30 Basis Points >U11.SG

6.05.2026 г., 23:11 ч. UTC

Печалби

United Overseas Bank's CEO: Low Single-Digit Operating Cost Growth Outlook for 2026>U11.SG

6.05.2026 г., 23:11 ч. UTC

Печалби

United Overseas Bank's CEO: 2026 Outlook for Full-Year NIM of 1.75%-1.80% >U11.SG

6.05.2026 г., 23:11 ч. UTC

Печалби

United Overseas Bank's CEO: High Single-Digit Fee Growth Outlook for 2026 >U11.SG

6.05.2026 г., 23:07 ч. UTC

Печалби

United Overseas Bank: 1Q Net Profit Decline Reflects Softer Operating Environment >U11.SG

6.05.2026 г., 23:06 ч. UTC

Печалби

United Overseas Bank 1Q Net Fee Income S$637M Vs. S$694M >U11.SG

6.05.2026 г., 23:06 ч. UTC

Печалби

United Overseas Bank 1Q Net Interest Income S$2.32B Vs. S$2.41B >U11.SG

6.05.2026 г., 23:05 ч. UTC

Печалби

United Overseas Bank 1Q Net S$1.44B Vs. Net S$1.49B >U11.SG

6.05.2026 г., 23:04 ч. UTC

Печалби

United Overseas Bank 1Q Total Income S$3.42B Vs. S$3.66B >U11.SG

6.05.2026 г., 22:50 ч. UTC

Печалби

Sarepta Stock Sinks on Earnings Beat. Elevidys Demand Faces a Reality Check. -- Barrons.com

6.05.2026 г., 22:25 ч. UTC

Пазарно говорене

Canada's Public Finances on Sustainable Path, BOC's Macklem Says -- Market Talk

6.05.2026 г., 22:11 ч. UTC

Печалби

Taseko Mines Ltd. 1Q Adj EPS C$0.08 >TKO.LN

6.05.2026 г., 22:11 ч. UTC

Печалби

Taseko Mines Ltd. 1Q EPS C$0.05 >TKO.LN

6.05.2026 г., 22:05 ч. UTC

Пазарно говорене

Updated Govt Fiscal Plan Won't Have Sizable Impact on BOC Outlook -- Market Talk

6.05.2026 г., 21:58 ч. UTC

Печалби

Arm Stock Takes Wild Ride After Earnings. Demand Might Be Too Strong to Meet. -- Barrons.com

6.05.2026 г., 21:47 ч. UTC

Пазарно говорене

Печалби

Costco Posts 13% Sales Growth in April -- Market Talk

6.05.2026 г., 21:46 ч. UTC

Печалби

IonQ Doubles Down on Nvidia Comparison. Why the Stock Is Falling After Blowout Earnings. -- Barrons.com

6.05.2026 г., 21:40 ч. UTC

Печалби

Arm Stock Takes Wild Ride After Earnings. Demand Might Be Too Strong to Meet. -- Barrons.com

6.05.2026 г., 21:35 ч. UTC

Пазарно говорене

BOC's Macklem Defends Warning About Rate Hikes to Fight Inflation -- Market Talk

6.05.2026 г., 21:32 ч. UTC

Горещи акции

Stocks to Watch Wednesday Recap: Advanced Micro Devices, Flutter, Disney, Uber -- WSJ

6.05.2026 г., 21:29 ч. UTC

Печалби

Fastly Stock Tumbles. An Earnings Beat Pauses a Monster Rally. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Odonate Therapeutics Inc Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

EBITDA

Оперативна печалба

Относно Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.